Join the Lucemyra group to help and get support from people like you.
Lucemyra News
FDA Approves Lucemyra (lofexidine hydrochloride) as the First Non-Opioid Treatment for Management of Opioid Withdrawal Symptoms
May 16, 2018 – The U.S. Food and Drug Administration today approved Lucemyra (lofexidine hydrochloride) for the mitigation of withdrawal symptoms to facilitate abrupt discontinuation of opioids in...
Ask a question
To post your own question to this support group, sign in or create an account.